Free Trial
NASDAQ:PAHC

Phibro Animal Health (PAHC) Stock Price, News & Analysis

$21.53
-0.46 (-2.09%)
(As of 04:00 PM ET)
Today's Range
$21.09
$22.16
50-Day Range
$16.39
$21.99
52-Week Range
$9.40
$22.31
Volume
179,955 shs
Average Volume
147,739 shs
Market Capitalization
$871.97 million
P/E Ratio
67.28
Dividend Yield
2.23%
Price Target
$15.00

Phibro Animal Health MarketRank™ Stock Analysis

Analyst Rating
Strong Sell
1.40 Rating Score
Upside/​Downside
29.9% Downside
$15.00 Price Target
Short Interest
Healthy
2.23% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-3.93
Upright™ Environmental Score
News Sentiment
0.95mentions of Phibro Animal Health in the last 14 days
Based on 19 Articles This Week
Insider Trading
Acquiring Shares
$100,100 Bought Last Quarter
Proj. Earnings Growth
8.11%
From $1.48 to $1.60 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.88 out of 5 stars

Medical Sector

212th out of 927 stocks

Pharmaceutical Preparations Industry

98th out of 425 stocks

PAHC stock logo

About Phibro Animal Health Stock (NASDAQ:PAHC)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, industrial, environmental, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

PAHC Stock Price History

PAHC Stock News Headlines

It’s over.
We found a tiny company which provides the backbone for the entire $15.7 trillion AI industry... It's used by EVERY single AI company on the planet... AMD, NVIDIA, META... none of these companies could exist without this firm.
It’s over.
We found a tiny company which provides the backbone for the entire $15.7 trillion AI industry... It's used by EVERY single AI company on the planet... AMD, NVIDIA, META... none of these companies could exist without this firm.
Phibro Animal Health (PAHC) Receives a Sell from Barclays
See More Headlines
Receive PAHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phibro Animal Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/31/2023
Ex-Dividend for 6/26 Dividend
6/05/2024
Dividend Payable
6/26/2024
Ex-Dividend for 9/25 Dividend
9/04/2024
Today
9/16/2024
Dividend Payable
9/25/2024
Next Earnings (Estimated)
11/13/2024
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PAHC
Employees
1,940
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$15.00
High Stock Price Target
$22.00
Low Stock Price Target
$9.00
Potential Upside/Downside
-29.4%
Consensus Rating
Strong Sell
Rating Score (0-4)
1.40
Research Coverage
5 Analysts

Profitability

Net Income
$2.42 million
Pretax Margin
1.07%

Debt

Sales & Book Value

Annual Sales
$1.02 billion
Cash Flow
$2.20 per share
Book Value
$6.34 per share

Miscellaneous

Free Float
20,227,000
Market Cap
$860.22 million
Optionable
Optionable
Beta
0.52
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Jack Clifford BendheimMr. Jack Clifford Bendheim (Age 77)
    Chairman, President & CEO
    Comp: $2.9M
  • Mr. Larry L. Miller (Age 60)
    Chief Operating Officer
    Comp: $774.91k
  • Mr. Daniel M. Bendheim (Age 52)
    Executive VP of Corporate Strategy & Director
    Comp: $548.18k
  • Mr. Rob Aukerman (Age 66)
    President of North America Region
    Comp: $619.27k
  • Mr. Glenn C. David (Age 51)
    Chief Financial Officer
  • Ms. Judith A. Weinstein (Age 55)
    Senior VP, General Counsel & Corporate Secretary
  • Ms. Lisa A. Escudero (Age 62)
    Senior Vice President of Human Resources
  • Mr. Jonathan Bendheim (Age 48)
    President of MACIE Region, GM of Israel Operations & Director
  • Mr. Ramon Fuenmayor
    President South America Region
  • Mr. Samson Li (Age 52)
    President of Asia Pacific Region

PAHC Stock Analysis - Frequently Asked Questions

How have PAHC shares performed this year?

Phibro Animal Health's stock was trading at $11.58 at the beginning of 2024. Since then, PAHC stock has increased by 84.8% and is now trading at $21.40.
View the best growth stocks for 2024 here
.

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Co. (NASDAQ:PAHC) issued its quarterly earnings results on Thursday, August, 31st. The company reported $0.38 EPS for the quarter, missing analysts' consensus estimates of $0.40 by $0.02. The company had revenue of $255 million for the quarter, compared to the consensus estimate of $256.68 million. Phibro Animal Health had a trailing twelve-month return on equity of 18.08% and a net margin of 0.24%.

Who are Phibro Animal Health's major shareholders?

Top institutional shareholders of Phibro Animal Health include Brandes Investment Partners LP (5.94%), Pzena Investment Management LLC (4.54%), Dimensional Fund Advisors LP (1.91%) and Acadian Asset Management LLC (1.77%).
View institutional ownership trends
.

How do I buy shares of Phibro Animal Health?

Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Intercept Pharmaceuticals (ICPT) and VIVUS (VVUS).

This page (NASDAQ:PAHC) was last updated on 9/16/2024 by MarketBeat.com Staff

From Our Partners